March 2024
1. TANNE JH
   US Supreme Court questions legitimacy of case seeking to ban mifepristone.
   BMJ. 2024;384:q763.
   

   >> Share

   
   
2. ROLAND N, Neumann A, Hoisnard L, Duranteau L, et al
   Use of progestogens and the risk of intracranial meningioma: national case-control study.
   BMJ. 2024;384:e078078.
   

   >> Share

   
   February 2024
3. MCNEE R
   Tackling contraceptive misinformation on social media.
   BMJ. 2024;384:q472.
   

   >> Share

   
   
4. LOOI MK
   The grey area of "fertility tech" being mis-sold as contraception.
   BMJ. 2024;384:q54.
   

   >> Share

   
   December 2023
5. WAGNER B, Cleland K
   Retail demand for emergency contraception in United States following New Year holiday: time series study.
   BMJ. 2023;383:e077437.
   

   >> Share

   
   November 2023
6. LIMB M
   Pharmacy health checks and contraceptive service could save 10 million GP appointments.
   BMJ. 2023;383:p2722.
   

   >> Share

   
   September 2023
7. MEAIDI A
   Filling in the gaps in our understanding of hormonal contraception.
   BMJ. 2023;382:2043.
   

   >> Share

   
   
8. SCHMIDT M
   NSAIDs, hormonal contraception, and venous thromboembolism.
   BMJ. 2023;382:p1990.
   

   >> Share

   
   
9. MEAIDI A, Mascolo A, Sessa M, Toft-Petersen AP, et al
   Venous thromboembolism with use of hormonal contraception and non-steroidal anti-inflammatory drugs: nationwide cohort study.
   BMJ. 2023;382:e074450.
   

   >> Share

   
   August 2023
10. TANNE JH
    US federal court upholds limits on abortion drug mifepristone.
    BMJ. 2023;382:1924.
    

    >> Share

    
    
11. TANNE JH
    Combining anti-inflammatory drug with the morning after pill boosts effectiveness, study finds.
    BMJ. 2023;382:1920.
    

    >> Share

    
    July 2023
12. TANNE JH
    FDA approves daily over-the-counter oral contraceptive with no age restrictions.
    BMJ. 2023;382:p1631.
    

    >> Share

    
    April 2023
13. TANNE JH
    US Supreme Court allows mifepristone to remain available for now.
    BMJ. 2023;381:p923.
    

    >> Share

    
    
14. MCNALLY S
    Scarlett McNally: Let's talk about contraception.
    BMJ. 2023;381:p862.
    

    >> Share

    
    
15. TANNE JH
    Mifepristone remains available in US until midnight on 19 April.
    BMJ. 2023;381:864.
    

    >> Share

    
    
16. TANNE JH
    Opposing rulings on mifepristone in US leave access to medical abortion in jeopardy.
    BMJ. 2023;381:822.
    

    >> Share

    
    January 2023
17. THORNTON J
    Demand for abortions surges as contraception services shrink and cost of living rises.
    BMJ. 2023;380:237.
    

    >> Share

    
    December 2022
18. KMIETOWICZ Z
    Emergency contraceptive pills don't induce abortion, says US regulator.
    BMJ. 2022;379:o3073.
    

    >> Share

    
    November 2022
19. IACOBUCCI G
    National scheme to offer emergency hormonal contraception in pharmacies will cut GP workload, say researchers.
    BMJ. 2022;379:o2832.
    

    >> Share

    
    July 2022
20. TANNE JH
    Drug company asks FDA to approve over-the-counter contraceptive pill.
    BMJ. 2022;378:o1727.
    

    >> Share

    
    March 2022
21. CAMERON S, Reynolds-Wright J
    Mifepristone at home.
    BMJ. 2022;376:o819.
    

    >> Share

    
    
22. SAUL H, Gursul D, Cassidy S, Vinogradova Y, et al
    Risk of breast cancer with HRT depends on therapy type and duration.
    BMJ. 2022;376:o485.
    

    >> Share

    
    November 2020
23. YLAND JJ, Bresnick KA, Hatch EE, Wesselink AK, et al
    Pregravid contraceptive use and fecundability: prospective cohort study.
    BMJ. 2020;371:m3966.
    

    >> Share

    
    October 2020
24. OKOTH K, Chandan JS, Marshall T, Thangaratinam S, et al
    Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review.
    BMJ. 2020;371:m3502.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share